Genesis Biotechnology Group News and Activities
Presence
Headquarters: United States (USA)
Genesis Biotechnology Group has 3 subsidiaries including Genesis Drug Discovery & Development, Genesis Investment Properties and Medical Diagnostic Laboratories.
They are in:
- Biotechnology75%
- Real Estate25%
Executives
View the org chart displaying its 47 main executives
Most searched biographies at Genesis Biotechnology Group
- Eli Mordechai, Chief Executive Officer
- Boris Bogomolnik, Chief Information Officer
- Susan Kase, Chief Legal Officer
Create your alert
to follow the executive moves at Genesis Biotechnology Group.
Biotechnology
Genesis Biotechnology Group has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).
Popular M&A news in Biotechnology
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
- IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
Popular contacts in Biotechnology
News
Press releases by Genesis Biotechnology Group
- 404 | Genesis Biotechnology Group
- https://www.genesisbiotechgroup.com/press/GD3_JSS.pdf
- https://www.genesisbiotechgroup.com/press/pr_organochem.pdf
- http://www.genesisbiotechgroup.com/press/MDL_Urology_Testing_3.9.2021.pdf
- Publications | GBG
- Patents | GBG
- News | GBG
- http://www.genesisbiotechgroup.com/press/CBI_Acquisition.pdf
- http://www.genesisbiotechgroup.com/press/COVID_NY_Exapansion_PR_FINALBranded_5.18.2020.pdf
- http://www.genesisbiotechgroup.com/press/COVID_Serol_PR_FINAL_Branded_4.29.2020v2.pdf
- View more press releases Close
Social media about Genesis Biotechnology Group
- Genesis Biotechnology Group on Wikipedia, Google News & Yahoo Finance
- Genesis Biotechnology Group on LinkedIn, X (Twitter) & YouTube
